Pendium

Step 1 of 9

AI agents treat La Roche-Posay as the canonical answer for clinical skincare, owning the most valuable category prompts.

With a visibility score of 84, the focus is now on defending the lead against fast-moving indie competitors and compounding your authority in the serum space.

La Roche-Posay's baseline score
84/100
Excellent

La Roche-Posay dominates the clinical skincare conversation, especially in sun care and barrier repair. While visibility is excellent, there is room to improve dominance in the anti-aging serum category where AI agents currently present a more fragmented set of recommendations.

What we see
  • La Roche-Posay is a default recommendation for sun care and eczema, frequently appearing as the first or second option in AI responses.
  • The brand's newer Mela B3 and Hyalu B5 serums are well-known but face heavier competition from The Ordinary and SkinCeuticals in AI discovery.
  • AI agents highly value the brand's 'dermatologist recommended' status, which acts as a filter for safety-focused queries.
  • Local AI visibility via AI Overviews is strong due to widespread availability in Walgreens, CVS, and Target locations.
  • There is a slight lag in AI recognition of the Mela B3 'Melasyl' breakthrough compared to the established Anthelios line.
Business goals La Roche-Posay is likely trying to hit
  • Maintain dominance as the top dermatologist-recommended brand for sensitive skin
  • Drive adoption of new proprietary Melasyl technology in the dark spot treatment market
  • Increase market share in the premium sun care category against medical-exclusive competitors
  • Expand the Lipikar line's presence in the pediatric and eczema-care segments